Literature DB >> 29973305

Heat Stress and Thermal Ablation Induce Local Expression of Nerve Growth Factor Inducible (VGF) in Hepatocytes and Hepatocellular Carcinoma: Preclinical and Clinical Studies.

Scott M Thompson1, Danielle E Jondal1, Kim A Butters1, Bruce E Knudsen1, Jill L Anderson1, Lewis R Roberts2, Matthew R Callstrom1, David A Woodrum1.   

Abstract

The purposes of this study were to test the hypothesis that heat stress and hepatic thermal ablation induce nerve growth factor inducible (VGF) and to determine intrahepatic versus systemic VGF expression induced by thermal ablation in vivo and in patients. Hepatocytes and HCC cells were subjected to moderate (45°C) or physiologic (37°C) heat stress for 10 min and assessed for VGF expression at 0-72 h post-heat stress (n ≥ 3 experiments). Orthotopic N1S1 HCC-bearing rats were randomized to sham or laser thermal ablation (3 W × 90 s), and liver/serum was harvested at 0-7 days postablation for analysis of VGF expression (n ≥ 6 per group). Serum was collected from patients undergoing thermal ablation for HCC (n = 16) at baseline, 3-6, and 18-24 h postablation and analyzed for VGF expression. Data were analyzed using ordinary or repeated-measures one-way analysis of variance and post hoc pairwise comparison with Dunnett's test. Moderate heat stress induced time-dependent VGF mRNA (3- to 15-fold; p < 0.04) and protein expression and secretion (3.1- to 3.3-fold; p < 0.05). Thermal ablation induced VGF expression at the hepatic ablation margin at 1 and 3 days postablation but not remote from the ablation zone or distant intrahepatic lobe. There was no detectable serum VGF following hepatic thermal ablation in rats and no increase in serum VGF following HCC thermal ablation in patients at 3-6 and 18-24 h postablation compared to baseline (0.71- and 0.63-fold; p = 0.27 and p = 0.16, respectively). Moderate heat stress induces expression and secretion of VGF in HCC cells and hepatocytes in vitro, and thermal ablation induces local intrahepatic but not distant intrahepatic or systemic VGF expression in vivo.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29973305      PMCID: PMC6290322          DOI: 10.3727/105221618X15305531034617

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  55 in total

1.  PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.

Authors:  Matthew P Stokes; Charles L Farnsworth; Albrecht Moritz; Jeffrey C Silva; Xiaoying Jia; Kimberly A Lee; Ailan Guo; Roberto D Polakiewicz; Michael J Comb
Journal:  Mol Cell Proteomics       Date:  2012-02-09       Impact factor: 5.911

2.  Large-scale phosphorylation analysis of mouse liver.

Authors:  Judit Villén; Sean A Beausoleil; Scott A Gerber; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 3.  Advances in the regulation of liver regeneration.

Authors:  Changku Jia
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 3.869

4.  Analysis of patients with rapid aggressive tumor progression of hepatocellular carcinoma after percutaneous radiofrequency ablation.

Authors:  Kazue Shiozawa; Manabu Watanabe; Masayoshi Takahashi; Noritaka Wakui; Kazunari Iida; Yasukiyo Sumino
Journal:  Hepatogastroenterology       Date:  2009 Nov-Dec

5.  Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.

Authors:  Gaurav Kumar; S Nahum Goldberg; Svetlana Gourevitch; Tatyana Levchenko; Vladimir Torchilin; Eithan Galun; Muneeb Ahmed
Journal:  Radiology       Date:  2017-09-06       Impact factor: 11.105

6.  Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Mohamed A Chinnaratha; Ming-yu Anthony Chuang; Robert J L Fraser; Richard J Woodman; Alan J Wigg
Journal:  J Gastroenterol Hepatol       Date:  2016-02       Impact factor: 4.029

7.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

8.  Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia.

Authors:  Guido Rindi; Lisa Licini; Vittorio Necchi; Lorena Bottarelli; Nicoletta Campanini; Cinzia Azzoni; Maurizio Favret; Giovanna Giordano; Filomena D'Amato; Carla Brancia; Enrico Solcia; Gian-Luca Ferri
Journal:  J Clin Endocrinol Metab       Date:  2007-04-17       Impact factor: 5.958

9.  Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.

Authors:  Gaurav Kumar; S Nahum Goldberg; Yuanguo Wang; Erik Velez; Svetlana Gourevitch; Eithan Galun; Muneeb Ahmed
Journal:  Eur Radiol       Date:  2016-06-10       Impact factor: 5.315

10.  Complementary PTM Profiling of Drug Response in Human Gastric Carcinoma by Immunoaffinity and IMAC Methods with Total Proteome Analysis.

Authors:  Matthew P Stokes; Charles L Farnsworth; Hongbo Gu; Xiaoying Jia; Camilla R Worsfold; Vicky Yang; Jian Min Ren; Kimberly A Lee; Jeffrey C Silva
Journal:  Proteomes       Date:  2015-08-07
View more
  1 in total

1.  Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model.

Authors:  Danielle E Jondal; Scott M Thompson; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Radiology       Date:  2019-07-23       Impact factor: 11.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.